The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Share

Personal info

View

Links

Table of contents

Affiliations

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Jean-Louis Chiasson

Research Centre

Centre Hospitalier de l'Université de Montréal

Department of Medicine

Université de Montréal

Canada. Jean-Louis Chiasson

[email]@umontreal.ca

Name/email consistency: high

[Claim this account]

Affiliations

Research Centre, Centre Hospitalier de l'Université de Montréal, Department of Medicine, Université de Montréal, Canada. Jean-Louis Chiasson. 2003 - 2009
Université de Montréal, Research Group on Diabetes and Metabolic Regulation Research Centre, CHUM - Hôtel-Dieu, Department of Medicine, Canada. 2001 - 2007
Research Centre-CHUM-Hôtel-Dieu, 3850 St. Urbain St., Rm. 8-202, Montreal (Quebec) H2W 1T7, Canada. 2004

References

Early insulin use in type 2 diabetes: what are the cons? Chiasson, J.L. Diabetes. Care (2009) [Pubmed]
Prevention of Type 2 diabetes: fact or fiction? Chiasson, J.L. Expert. Opin. Pharmacother (2007) [Pubmed]
The prevention of type 2 diabetes: what is the evidence?. Chiasson, J.L., Brindisi, M.C., Rabasa-Lhoret, R. Minerva Endocrinol. (2005) [Pubmed]
Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data. Chiasson, J.L., Josse, R.G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M. Diabetologia (2004) [Pubmed]
Prevention of type 2 diabetes: insulin resistance and beta-cell function. Chiasson, J.L., Rabasa-Lhoret, R. Diabetes (2004) [Pubmed]
Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Chiasson, J.L., Aris-Jilwan, N., Bélanger, R., Bertrand, S., Beauregard, H., Ekoé, J.M., Fournier, H., Havrankova, J. CMAJ (2003) [Pubmed]
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. Chiasson, J.L., Josse, R.G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M. JAMA (2003) [Pubmed]
The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes. Chiasson, J.L., Naditch, L. Diabetes. Care (2001) [Pubmed]

WikiGenes - Universities